1. Safety of at home teletherapy assisted KAP: https://www.sciencedirect.com/science/article/pii/S0165032722007625

2. https://www.sciencedirect.com/science/article/abs/pii/S0028390818300170

2. Phelps, J. (2017). Developing Guidelines and Competencies for the Training of Psychedelic Therapists.

3. A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression. https://www.nature.com/articles/s41398-020-00897-0

4. A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression. https://doi.org/10.1176/appi.ajp.2016.16010037

True healing is possible. ♡